In contrast, IL-6Rα-deficient tumours had less PCNA immunoreactivity compared with control tumours, whereas tumours from HFD-fed control mice had increased PCNA levels indicative of increased proliferation compared with NCD-fed controls (Supplementary Fig. 3g, h). This evidence concerns the gene IL6R and neoplasm.